Mohamed El-Dib, MD is the Director of Neonatal Neurocritical Care Brigham and Women’s Hospital (BWH) and Assistant Professor of Pediatrics at Harvard Medical School. He is a neonatologist with additional training in neonatal neurology. The BWH Neonatal Neurocritical program is a multidisciplinary group of specialty trained nurses, neurologists, neuroradiologists and developmental specialists. This group has established guidelines and protocols aiming at providing standardized, focused and integrated care for babies with or at risk for brain abnormality or injury. The Brigham and Women’s new state of the art NICU provides comprehensive care for neonates with neonatal encephalopathy including therapeutic hypothermia, neuromonitoring and neuroimaging.

Dr. El-Dib has numerous publications in the field of neonatal neurology. He has focused his research on neonatal neuromonitoring and neuroprotection. In neuromonitoring, he has used amplitude integrated EEG (aEEG) to evaluate brain maturation in premature infants and as a tool to evaluate for brain injury in neonatal encephalopathy. Dr. El-Dib has also has been investigating the use of near infra-red spectroscopy (NIRS) to assess cerebral circulation, oxygenation and oxygen metabolism in these population. Regarding neuroprotection, he has been a co-investigator in multiple studies on various neuroprotective agents including ascorbic acid, ibuprofen, melatonin and more recently autologous cord blood.